Department of Cytobiochemistry, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Mol Biol Rep. 2012 Jul;39(7):7795-804. doi: 10.1007/s11033-012-1622-z. Epub 2012 Apr 28.
TopBP1 protein displays structural as well as functional similarities to BRCA1 and is involved in DNA replication, DNA damage checkpoint response and transcriptional regulation. Aberrant expression of TopBP1 may lead to genomic instability and can have pathological consequences. In this study we aimed to investigate expression of TopBP1 gene at mRNA and protein level in hereditary breast cancer. Real-time quantitative PCR was performed in 127 breast cancer samples. Expression of TopBP1 mRNA in lobular carcinoma was significantly lower compared with ductal carcinoma (p < 0.05). The level of TopBP1 mRNA appeared to be lower in poorly differentiated (III grade) hereditary breast cancer in comparison with moderately (II grade) and well-differentiated cancer (I grade) (p < 0.05 and p < 0.001 respectively). We analyzed TopBP1 protein expression using immunohistochemistry and Western blot techniques. Expression of TopBP1 protein was found to be significantly increased in poorly differentiated breast cancer (III grade) (p < 0.05). The percentage of samples with cytoplasmic apart from nuclear staining increased with increasing histological grade. There was no significant association between level and intracellular localization of TopBP1 protein in hereditary breast cancer and other clinicopathological parameters such as estrogen and progesterone receptors status, appearance of metastasis in the axillary lymph nodes and type of cancer. Our data suggest that decreased level of TopBP1 mRNA and increased level of TopBP1 protein might be associated with progression of hereditary breast cancer.
TopBP1 蛋白在结构和功能上都与 BRCA1 相似,参与 DNA 复制、DNA 损伤检查点反应和转录调控。TopBP1 的异常表达可能导致基因组不稳定,并可能产生病理后果。在本研究中,我们旨在研究遗传性乳腺癌中 TopBP1 基因在 mRNA 和蛋白水平上的表达。对 127 个乳腺癌样本进行了实时定量 PCR。与导管癌相比,小叶癌中 TopBP1 mRNA 的表达明显降低(p<0.05)。与中分化(II 级)和高分化(I 级)相比,低分化(III 级)遗传性乳腺癌中 TopBP1 mRNA 的水平似乎较低(p<0.05 和 p<0.001)。我们使用免疫组织化学和 Western blot 技术分析了 TopBP1 蛋白的表达。在低分化乳腺癌(III 级)中发现 TopBP1 蛋白的表达显著增加(p<0.05)。细胞质染色而非核染色的样本百分比随组织学分级的增加而增加。在遗传性乳腺癌和其他临床病理参数(如雌激素和孕激素受体状态、腋窝淋巴结转移的出现和癌症类型)中,TopBP1 蛋白的水平和细胞内定位之间没有显著关联。我们的数据表明,TopBP1 mRNA 水平降低和 TopBP1 蛋白水平升高可能与遗传性乳腺癌的进展有关。